Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil

Author(s):Show less -

Castro Gomes, Claudia Maria ; Teixeira Sousa, Maria Gloria ; Bezerra Menezes, Joyce Prieto ; Batista, Marliane Campos ; Stocco Lima, Ana Carolina ; Belda, Jr., Walter ; Bradshaw, Daniel ; Alves Gama, Monica Elinor ; Laurenti, Marcia Dalastra ; Silveira, Fernando Tobias ; Pereira Corbett, Carlos Eduardo

• Document type: Journal article
• Source: Parasitology Research; v. 116, n. 5, p. 1423-1431, MAY 2017.
• Web of Science Citations: 2

Abstract

American cutaneous leishmaniasis (ACL) is a chronic infectious disease caused by different protozoan species of Leishmania, and it is endemic in both tropical and subtropical countries. Using immunohistochemistry, we investigate the density of CD68(+), lysozyme(+), CD1a(+), factor XIIIa(+), CD4(+), CD8(+), CD56(+), interferon (IFN)-gamma(+), and inducible NO synthase (iNOS(+)) cells. These cells were analyzed from 22 biopsy samples obtained from the lesions of ACL patients, whose infection was caused by Leishmania (Viannia) spp. Histopathological analysis showed dense mononuclear inflammatory infiltration in the dermis, which was composed of lymphocytes, macrophages, plasma cells, and discrete tissue parasitism. Granulomatous reactions were also present in the majority of cases. The density of the activated macrophages was higher than that of inactivated macrophages in the lesions. The density of Langerhans cells (CD1a(+)) was lower than that of dermal dendrocytes (factor XIIIa(+)). The density of CD8(+) T lymphocytes was higher than that of CD4(+) T lymphocytes. The cellular density of these immunological markers in relation to the species of Leishmania demonstrated that L. (Viannia) sp. lesions had higher IFN-gamma expression than that Leishmania (Viania) braziliensis lesions. The evaluation of these markers, according to disease progression, did not reveal any significant differences. L. (Viannia) sp. infection leads to a favorable immune response in the host, as predominantly represented by lysozyme(+), factor XIIIa(+), CD8(+) T cells, and the expression of (IFN)-gamma(+) at the lesion site. (AU)

• FAPESP's process: 06/56319-1 - Leishmaniasis in Brazil: clinical and immunopathogenetic aspects of the human and experimental disease
• Grantee: Carlos Eduardo Pereira Corbett
• Support Opportunities: Research Projects - Thematic Grants